Literature DB >> 19154344

A systems biological approach suggests that transcriptional feedback regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in RAS-transformed fibroblasts.

Nils Blüthgen1, Stefan Legewie, Szymon M Kielbasa, Anja Schramme, Oleg Tchernitsa, Jana Keil, Andrea Solf, Martin Vingron, Reinhold Schäfer, Hanspeter Herzel, Christine Sers.   

Abstract

Mitogen-activated protein kinase (MAPK) signaling determines crucial cell fate decisions in most cell types, and mediates cellular transformation in many types of cancer. The activity of MAPK is controlled by reversible phosphorylation, and the quantitative characteristics of MAPK activation determine the cellular response. Many systems biological studies have analyzed the activation kinetics and the dose-response behavior of the MAPK signaling pathway. Here we investigate how the pathway activity is controlled by transcriptional feedback loops. Initially, we predict that MAPK signaling regulates phosphatases, by integrating promoter sequence data and ontology-based classification of gene function. From this, we deduce that MAPK signaling might be controlled by transcriptional negative feedback regulation via dual-specificity phosphatases (DUSPs), and implement a mathematical model to further test this hypothesis. Using time-resolved measurements of pathway activity and gene expression, we employ a model selection approach, and select DUSP6 as a highly likely candidate for shaping the activity of the MAPK pathway during cellular transformation caused by oncogenic RAS. Two predictions from the model were confirmed: first, feedback regulation requires that DUSP6 mRNA and protein are unstable; and second, the activation kinetics of MAPK are ultrasensitive. Taken together, an integrated systems biological approach reveals that transcriptional negative feedback controls the kinetics and the extent of MAPK activation under both physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154344     DOI: 10.1111/j.1742-4658.2008.06846.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  24 in total

1.  DUSP4 regulates neuronal differentiation and calcium homeostasis by modulating ERK1/2 phosphorylation.

Authors:  Sun Young Kim; Yong-Mahn Han; Mihee Oh; Won-Kon Kim; Kyoung-Jin Oh; Sang Chul Lee; Kwang-Hee Bae; Baek-Soo Han
Journal:  Stem Cells Dev       Date:  2014-12-23       Impact factor: 3.272

Review 2.  Triple-negative breast cancer: present challenges and new perspectives.

Authors:  Franca Podo; Lutgarde M C Buydens; Hadassa Degani; Riet Hilhorst; Edda Klipp; Ingrid S Gribbestad; Sabine Van Huffel; Hanneke W M van Laarhoven; Jan Luts; Daniel Monleon; Geert J Postma; Nicole Schneiderhan-Marra; Filippo Santoro; Hans Wouters; Hege G Russnes; Therese Sørlie; Elda Tagliabue; Anne-Lise Børresen-Dale
Journal:  Mol Oncol       Date:  2010-04-24       Impact factor: 6.603

3.  Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2.

Authors:  Veronika Reiterer; Dirk Fey; Walter Kolch; Boris N Kholodenko; Hesso Farhan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

4.  Biology using engineering tools: the negative feedback amplifier.

Authors:  Marc R Birtwistle; Walter Kolch
Journal:  Cell Cycle       Date:  2011-07-01       Impact factor: 4.534

5.  A high-throughput assay for phosphoprotein-specific phosphatase activity in cellular extracts.

Authors:  Anjun K Bose; Kevin A Janes
Journal:  Mol Cell Proteomics       Date:  2012-12-11       Impact factor: 5.911

Review 6.  Robustness of signal transduction pathways.

Authors:  Nils Blüthgen; Stefan Legewie
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 7.  The dynamic control of signal transduction networks in cancer cells.

Authors:  Walter Kolch; Melinda Halasz; Marina Granovskaya; Boris N Kholodenko
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

8.  Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.

Authors:  Karsten Jürchott; Ralf-Jürgen Kuban; Till Krech; Nils Blüthgen; Ulrike Stein; Wolfgang Walther; Christian Friese; Szymon M Kiełbasa; Ute Ungethüm; Per Lund; Thomas Knösel; Wolfgang Kemmner; Markus Morkel; Johannes Fritzmann; Peter M Schlag; Walter Birchmeier; Tammo Krueger; Silke Sperling; Christine Sers; Hans-Dieter Royer; Hanspeter Herzel; Reinhold Schäfer
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

9.  RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.

Authors:  Pamela K Kreeger; Roli Mandhana; Shannon K Alford; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

Review 10.  Cancer systems biology: a network modeling perspective.

Authors:  Pamela K Kreeger; Douglas A Lauffenburger
Journal:  Carcinogenesis       Date:  2009-10-27       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.